Effect of tailoring anticoagulant treatment duration by applying a recurrence risk prediction model in patients with venous thromboembolism compared to usual care: A randomized controlled trial | ORKG Ask

We use cookies to provide a better user experience.

Data Protection

Related items

Effect of tailoring anticoagulant treatment duration by applying a recurrence risk prediction model in patients with venous thromboembolism compared to usual care: A randomized controlled trial.

Geert-Jan Geersing
Janneke M T Hendriksen
Nicolaas P A Zuithoff
Kit C Roes
Ruud Oudega
Toshihiko Takada
Roger E G Schutgens
Karel G M Moons

June 2020

BackgroundPatients with unprovoked (i.e., without the presence of apparent transient risk factors su...

Individualizing treatment decisions for patients with venous thromboembolism : Risk prediction and patient preferences

Winter, Maria Adriana de

May 2022

Anticoagulation is the cornerstone of treatment for venous thromboembolism (VTE; deep vein thrombosi...

Prediction of risk of recurrence of venous thromboembolism following treatment for a first unprovoked venous thromboembolism: systematic review, prognostic model and clinical decision rule, and economic evaluation.

Ensor, J
Riley, RD
Jowett, S
Monahan, M
Snell, KIE
Bayliss, S
Moore, D
Fitzmaurice, D

February 2016

BACKGROUND: Unprovoked first venous thromboembolism (VTE) is defined as VTE in the absence of a temp...

Prediction of risk of recurrence of venous thromboembolism following treatment for a first unprovoked venous thromboembolism: systematic review, prognostic model and clinical decision rule, and economic evaluation

Joie Ensor
Richard D Riley
Sue Jowett
Mark Monahan
Kym IE Snell
Susan Bayliss
David Moore
David Fitzmaurice
on behalf of the PIT-STOP collaborative group

February 2016

Background: Unprovoked first venous thromboembolism (VTE) is defined as VTE in the absence of a temp...

Prediction of risk of recurrence of venous thromboembolism following treatment for a first unprovoked venous thromboembolism : systematic review, prognostic model and clinical decision rule, and economic evaluation

Ensor, Joie
Riley, Richard D.
Jowett, Sue
Monahan, Mark
Snell, Kym IE
Bayliss, Susan
Moore, David
Fitzmaurice, David

January 2016

Background Unprovoked first venous thromboembolism (VTE) is defined as VTE in the absence of a te...

Risk of recurrent venous thromboembolism according to baseline risk factor profiles

Prins, Martin H.
Lensing, Anthonie W. A.
Prandoni, Paolo
Wells, Philip S.
Verhamme, Peter
Beyer-Westendorf, Jan
Bauersachs, Rupert
Bounameaux, Henri
Brighton, Timothy A.
Cohen, Alexander T.
Davidson, Bruce L.
Decousus, Herve
Kakkar, Ajay K.
van Bellen, Bonno
Pap, Akos F.
Homering, Martin
Tamm, Miriam
Weitz, Jeffrey

April 2018

The optimal duration of anticoagulation for venous thromboembolism (VTE) is uncertain. In this presp...

Effect of tailoring anticoagulant treatment duration by applying a recurrence risk prediction model in patients with venous thromboembolism compared to usual care: A randomized controlled trial.

Geert-Jan Geersing
Janneke M T Hendriksen
Nicolaas P A Zuithoff
Kit C Roes
Ruud Oudega
Toshihiko Takada
Roger E G Schutgens
Karel G M Moons

June 2020

BackgroundPatients with unprovoked (i.e., without the presence of apparent transient risk factors su...

Prediction of risk of recurrence of venous thromboembolism following treatment for a first unprovoked venous thromboembolism: systematic review, prognostic model and clinical decision rule, and economic evaluation.

Ensor, J
Riley, RD
Jowett, S
Monahan, M
Snell, KIE
Bayliss, S
Moore, D
Fitzmaurice, D

February 2016

BACKGROUND: Unprovoked first venous thromboembolism (VTE) is defined as VTE in the absence of a temp...

Prediction of risk of recurrence of venous thromboembolism following treatment for a first unprovoked venous thromboembolism: systematic review, prognostic model and clinical decision rule, and economic evaluation

Joie Ensor
Richard D Riley
Sue Jowett
Mark Monahan
Kym IE Snell
Susan Bayliss
David Moore
David Fitzmaurice
on behalf of the PIT-STOP collaborative group

February 2016

Background: Unprovoked first venous thromboembolism (VTE) is defined as VTE in the absence of a temp...

Prediction of risk of recurrence of venous thromboembolism following treatment for a first unprovoked venous thromboembolism : systematic review, prognostic model and clinical decision rule, and economic evaluation

Ensor, Joie
Riley, Richard D.
Jowett, Sue
Monahan, Mark
Snell, Kym IE
Bayliss, Susan
Moore, David
Fitzmaurice, David

January 2016

Background Unprovoked first venous thromboembolism (VTE) is defined as VTE in the absence of a te...

Risk of recurrent venous thromboembolism according to baseline risk factor profiles

Prins, Martin H.
Lensing, Anthonie W. A.
Prandoni, Paolo
Wells, Philip S.
Verhamme, Peter
Beyer-Westendorf, Jan
Bauersachs, Rupert
Bounameaux, Henri
Brighton, Timothy A.
Cohen, Alexander T.
Davidson, Bruce L.
Decousus, Herve
Kakkar, Ajay K.
van Bellen, Bonno
Pap, Akos F.
Homering, Martin
Tamm, Miriam
Weitz, Jeffrey

April 2018

The optimal duration of anticoagulation for venous thromboembolism (VTE) is uncertain. In this presp...